Literature DB >> 6874068

Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.

D B Burlington, M L Clements, G Meiklejohn, M Phelan, B R Murphy.   

Abstract

The isotype-specific antibody responses to purified hemagglutinin of adults undergoing either primary or secondary infection with an influenza A virus were characterized by using an enzyme-linked immunosorbent assay. Twenty-eight military recruits undergoing primary infection with A/USSR/92/77 (H1N1)-like virus had serum antibody rises in the immunoglobulin M (IgM) (86%), IgG (100%), and IgA (96%) isotypes. In contrast, 19 adult volunteers undergoing secondary infection with A/Peking/2/79 (H3N2) wild-type virus had serum antibody titer rises largely restricted to the IgG (68%) and IgA (74%) classes, with only 1 volunteer having a serum IgM antibody titer rise. Nasal wash hemagglutinin-specific antibody responses in the adults undergoing secondary infection were predominantly in the IgA class (74%). There was a correlation between the presence of and the magnitude of nasal wash and serum hemagglutinin-specific IgA antibody responses in these adults. This suggested that there was a common source for the hemagglutinin-specific local IgA antibody and serum IgA antibody produced after infection. The recruits undergoing primary H1N1 influenza virus infection had H1 hemagglutinin-specific enzyme-linked immunosorbent assay antibody in each of the IgA, IgG, and IgM isotypes in their acute-phase serum. However, no role for this cross-reactive antibody in modifying the severity of illness experienced by the recruits could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874068      PMCID: PMC264675          DOI: 10.1128/iai.41.2.540-545.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  SUPPRESSION OF MEASLES 19S ANTIBODY FORMATION AS EVIDENCE OF IMMUNITY. PRIMARY IMMUNE RESPONSE MASKED BY MATERIAL ANTIBODY.

Authors:  A SCHLUEDERBERG; S KARELITZ
Journal:  JAMA       Date:  1965-03-29       Impact factor: 56.272

2.  Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.

Authors:  S A Plotkin; J D Farquhar; P L Ogra
Journal:  JAMA       Date:  1973-08-06       Impact factor: 56.272

3.  Immunoglobulin class of influenza antibodies investigated by radioimmunoassay (RIA).

Authors:  H Daugharty; M L Davis; H S Kaye
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

4.  Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75.

Authors:  M Verhoeyen; R Fang; W M Jou; R Devos; D Huylebroeck; E Saman; W Fiers
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

5.  Serum IgM antibody and influenza A infection.

Authors:  Y I Buchner; R B Heath; J V Collins; J R Pattison
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

6.  Detection of enterovirus specific IgG and IgM antibodies in humans by an indirect solid phase radioimmunoassay.

Authors:  R Dörries; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

7.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

8.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Immunoglobulin M responses to the Norwalk virus of gastroenteritis.

Authors:  G Cukor; N A Nowak; N R Blacklow
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.

Authors:  B R Murphy; E L Tierney; B A Barbour; R H Yolken; D W Alling; H P Holley; R E Mayner; R M Chanock
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  36 in total

1.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

Review 2.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

3.  Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.

Authors:  Donald J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017.

Authors:  Eugenie Poirot; Min Z Levine; Kate Russell; Rebekah J Stewart; Justine M Pompey; Sophia Chiu; Alicia M Fry; Liaini Gross; Fiona P Havers; Zhu-Nan Li; Feng Liu; Aldo Crossa; Christopher T Lee; Vanessa Boshuizen; Jennifer L Rakeman; Sally Slavinski; Scott Harper; L Hannah Gould
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

5.  In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry.

Authors:  Joan E Nichols; Joaquin Cortiella; Jungwoo Lee; Jean A Niles; Meghan Cuddihy; Shaopeng Wang; Joseph Bielitzki; Andrea Cantu; Ron Mlcak; Esther Valdivia; Ryan Yancy; Matthew L McClure; Nicholas A Kotov
Journal:  Biomaterials       Date:  2008-11-29       Impact factor: 12.479

6.  Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination.

Authors:  P Rautenberg; I Teifke; T Schlegelberger; U Ullmann
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

Authors:  Mirian Mendoza; Angela Ballesteros; Qi Qiu; Luis Pow Sang; Soumya Shashikumar; Sofia Casares; Teodor-D Brumeanu
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

Review 8.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

9.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

10.  Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.

Authors:  Aleksandar Masic; Jayaum S Booth; George K Mutwiri; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.